Arax Advisory Partners’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Arax Advisory Partners’s Portfolio REVS Stock Details REVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.53M	Buy	+239,615	New	+$7.38M	0.05%	371

Other funds holding REVS

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FIB

First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Arax Advisory Partners's REVS Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Columbia Research Enhanced Value ETF (REVS) in Q2 2026: 239,615 shares worth $7.53M. The stake represents 0.05% of the portfolio and ranks #371 among its holdings.

37 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

Arax Advisory Partners held 239,615 shares of Columbia Research Enhanced Value ETF worth $7.53M as of Q2 2026.
Columbia Research Enhanced Value ETF was a new Arax Advisory Partners position in Q2 2026.
Columbia Research Enhanced Value ETF made up 0.05% of Arax Advisory Partners's portfolio in Q2 2026, its #371 holding.
37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.